FindTrial
Sign In

Study of the detection of basic leucine zipper transcription factor 2 (BATF2) in tumor tissues of lung cancer patients and its correlation with PD-L1 expression

Study of the detection of basic leucine zipper transcription factor 2 (BATF2) in tumor tissues of lung cancer patients and its correlation with PD-L1 expression

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033546
Enrollment
Unknown
Registered
2020-06-05
Start date
2020-06-10
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

High expression group of BATF2 in lung cancer:Nil
Low expression group of BATF2 in lung cancer:Nil

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. III stage non small cell lung cancer patients; 2. Patients with clear biopsy diagnosis; 3. Aged over 18 years; 4. Volunteered as subjects and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. People have other malignant tumor; 2. The researchers believe that the other condition lead to unsuitable to participate in the trial.

Design outcomes

Primary

MeasureTime frame
basic leucine zipper transcription factor 2 (BATF2);—

Countries

China

Contacts

Public ContactLiu Jun

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

tztuozhan@163.com+86 18827349083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026